Palacios E M, Martin A J, Boss M A, Ezekiel F, Chang Y S, Yuh E L, Vassar M J, Schnyer D M, MacDonald C L, Crawford K L, Irimia A, Toga A W, Mukherjee P
From the Departments of Radiology and Biomedical Imaging (E.M.P., A.J.M., F.E., Y.S.C., E.L.Y., P.M.).
National Institute of Standards and Technology (M.A.B.), Boulder, Colorado.
AJNR Am J Neuroradiol. 2017 Mar;38(3):537-545. doi: 10.3174/ajnr.A5025. Epub 2016 Dec 22.
Precision medicine is an approach to disease diagnosis, treatment, and prevention that relies on quantitative biomarkers that minimize the variability of individual patient measurements. The aim of this study was to assess the intersite variability after harmonization of a high-angular-resolution 3T diffusion tensor imaging protocol across 13 scanners at the 11 academic medical centers participating in the Transforming Research and Clinical Knowledge in Traumatic Brain Injury multisite study.
Diffusion MR imaging was acquired from a novel isotropic diffusion phantom developed at the National Institute of Standards and Technology and from the brain of a traveling volunteer on thirteen 3T MR imaging scanners representing 3 major vendors (GE Healthcare, Philips Healthcare, and Siemens). Means of the DTI parameters and their coefficients of variation across scanners were calculated for each DTI metric and white matter tract.
For the National Institute of Standards and Technology diffusion phantom, the coefficients of variation of the apparent diffusion coefficient across the 13 scanners was <3.8% for a range of diffusivities from 0.4 to 1.1 × 10 mm/s. For the volunteer, the coefficients of variations across scanners of the 4 primary DTI metrics, each averaged over the entire white matter skeleton, were all <5%. In individual white matter tracts, large central pathways showed good reproducibility with the coefficients of variation consistently below 5%. However, smaller tracts showed more variability, with the coefficients of variation of some DTI metrics reaching 10%.
The results suggest the feasibility of standardizing DTI across 3T scanners from different MR imaging vendors in a large-scale neuroimaging research study.
精准医学是一种疾病诊断、治疗和预防方法,它依赖于定量生物标志物,以尽量减少个体患者测量的变异性。本研究的目的是评估参与创伤性脑损伤转化研究与临床知识多中心研究的11个学术医疗中心的13台扫描仪,在统一高角分辨率3T扩散张量成像协议后的站点间变异性。
扩散磁共振成像采集自美国国家标准与技术研究院开发的新型各向同性扩散模型以及一名流动志愿者的脑部,使用了代表3家主要供应商(通用电气医疗集团、飞利浦医疗保健公司和西门子公司)的13台3T磁共振成像扫描仪。针对每个扩散张量成像指标和白质束,计算扩散张量成像参数的平均值及其在各扫描仪间的变异系数。
对于美国国家标准与技术研究院的扩散模型,在0.4至1.1×10⁻³mm²/s的扩散率范围内,13台扫描仪的表观扩散系数变异系数<3.8%。对于志愿者,4个主要扩散张量成像指标在整个白质骨架上的平均变异系数均<5%。在单个白质束中,大的中央通路显示出良好的可重复性,变异系数始终低于5%。然而,较小的白质束变异性更大,一些扩散张量成像指标的变异系数达到10%。
结果表明,在大规模神经影像学研究中,对来自不同磁共振成像供应商的3T扫描仪进行扩散张量成像标准化是可行的。